Which one predicts mortality better in acute ischemic stroke: negative vs positive acute-phase reactants

References

• Çubuk C, Efe Sayın C. Çankırı İli İnme Epidemiyolojisi ve Klinik Sonuçları. Türk Beyin Damar Hastalıkları Dergisi. 2021;27(1):34–41. doi: 10.5505/tbdhd.2021.82474
   Google Scholar
• Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol. 2007;6(2):182–187. doi: 10.1016/S1474-4422(07)70031-5
   PubMed Web of Science ®Google Scholar
• Johnson CO, Nguyen M, Roth GA, et al. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet Neurol. 2019;18(5):439–458. doi: 10.1016/S1474-4422(19)30034-1
   PubMed Web of Science ®Google Scholar
• Tamam Y, Iltumur K, Apak I. Assessment of acute phase proteins in acute ischemic stroke. Tohoku J Exp Med. 2005;206(2):91–98. doi: 10.1620/tjem.206.91
   PubMed Web of Science ®Google Scholar
• Di Napoli M, Di Gianfilippo G, Sollecito A, et al. C-reactive protein and outcome after first-ever ischemic stroke. Stroke. 2000;31(1):231–239. doi: 10.1161/01.STR.31.1.231-f
   PubMed Web of Science ®Google Scholar
• Sahan M, Sebe A, Acikalin A, et al. Acute-phase reactants and cytokines in ischemic stroke: do they have any relationship with short-term mortality. Eur Rev Med Pharmacol Sci. 2013;17(20):2773–2777.
   PubMed Web of Science ®Google Scholar
• Sahan M, Satar S, Koç AF, et al. İskemik inme ve akut faz reaktanları. Arşiv Kaynak Tarama Dergisi. 2010;19(2):85–140.
   Google Scholar
• Dewan K, Rana P. C–reactive protein and early mortality in acute ischemic stroke. Kathmandu University Medical Journal. 2011;9(4):252–255. doi: 10.3126/kumj.v9i4.6339
   PubMedGoogle Scholar
• Tuttolomondo A, Daidone M, Pinto A. Endothelial dysfunction and inflammation in ischemic stroke pathogenesis. Curr Pharm Des. 2020;26(34):4209–4219. doi: 10.2174/1381612826666200417154126
   PubMed Web of Science ®Google Scholar
• Chakraborty B, Vishnoi G, Goswami B, et al. Lipoprotein (a), ferritin, and albumin in acute phase reaction predicts severity and mortality of acute ischemic stroke in north Indian patients. J Stroke Cerebrovascular Dis. 2013;22(7):e159–e67. doi: 10.1016/j.jstrokecerebrovasdis.2012.10.013
   PubMed Web of Science ®Google Scholar
• Acalovschi D, Wiest T, Hartmann M, et al. Multiple levels of regulation of the interleukin-6 system in stroke. Stroke. 2003;34(8):1864–1869. doi: 10.1161/01.STR.0000079815.38626.44
   PubMed Web of Science ®Google Scholar
• An C, Hallenbeck J. The harms and benefits of inflammatory and immune responses in vascular disease. Stroke. 2006;37(2):291–293. doi: 10.1161/01.STR.0000200561.69611.f8
   PubMed Web of Science ®Google Scholar
• Zhou Y, Han W, Gong D, et al. Hs-CRP in stroke: a meta-analysis. Clinica Chimica Acta. 2016;453:21–27. doi: 10.1016/j.cca.2015.11.027
   PubMed Web of Science ®Google Scholar
• Hu Z, Lai J, Chen L, et al. Can baseline C-reactive protein level predict functional outcome in acute ischaemic stroke? A meta-analysis. Biomarkers. 2020;25(7):525–532. doi: 10.1080/1354750X.2020.1817982
   PubMed Web of Science ®Google Scholar
• Baker IA, Pickering J, Elwood PC, et al. Fibrinogen, viscosity and white blood cell count predict myocardial, but not cerebral infarction: evidence from the caerphilly and Speedwell cohort. Thromb Haemost. 2002;87(3):421–425. doi: 10.1055/s-0037-1613020
   PubMed Web of Science ®Google Scholar
• Lowe G, Rumley A, Norrie J, et al. Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland coronary prevention study. Thromb Haemost. 2000;84(10):553–558. doi: 10.1055/s-0037-1614066
   PubMedGoogle Scholar
• Helmy MA, Khodair RM, MH E-A, et al. Serum Level of Ferritin and fibrinogen as prognostic indicator for acute ischemic stroke. Benha medical journal. 2021;38(2):559–568.
   Google Scholar
• Davalos A, Castillo J, Marrugat J, et al. Body iron stores and early neurologic deterioration in acute cerebral infarction. Neurology. 2000;54(8):1568–1574. doi: 10.1212/WNL.54.8.1568
   PubMed Web of Science ®Google Scholar
• Erdemoglu A, Ozbakir S. Serum ferritin levels and early prognosis of stroke. Eur J Neurol. 2002;9(6):633–637. doi: 10.1046/j.1468-1331.2002.00472.x
   PubMed Web of Science ®Google Scholar
• Katan M, Moon YP, DeRosa J, et al. Procalcitonin, copeptin and midregional pro-atrial natriuretic peptide as markers of ischemic stroke risk: the northern Manhattan study. Stroke. 2014;45(suppl_1):A54–A. doi: 10.1161/str.45.suppl_1.54
   PubMedGoogle Scholar
• Zhang Y, Chen Z, Tang Y, et al. Association between procalcitonin levels and carotid atherosclerosis in acute ischemic stroke patients. Int J Neurosci. 2018;128(3):237–242. doi: 10.1080/00207454.2017.1387114
   PubMed Web of Science ®Google Scholar
• Arques S. Human serum albumin in cardiovascular diseases. Eur J Internal Med. 2018;52:8–12. doi: 10.1016/j.ejim.2018.04.014
   PubMed Web of Science ®Google Scholar
• Zhou H, Wang A, Meng X, et al. Low serum albumin levels predict poor outcome in patients with acute ischaemic stroke or transient ischaemic attack. Stroke Vasc Neurol. 2021;6(3):458–466. doi: 10.1136/svn-2020-000676
   PubMedGoogle Scholar
• Hu X, Li Y, Cheng P, et al. Serum level of TF unique peptide is decreased in patients with acute ischemic stroke. Front Neurol. 2021;12:619310. doi: 10.3389/fneur.2021.619310
   PubMedGoogle Scholar
• Altamura C, Squitti R, Pasqualetti P, et al. Ceruloplasmin/TF system is related to clinical status in acute stroke. Stroke. 2009;40(4):1282–1288. doi: 10.1161/STROKEAHA.108.536714
   PubMed Web of Science ®Google Scholar
• Chamorro Á. Role of inflammation in stroke and atherothrombosis. Cerebrovascular Dis. 2004;17(Suppl. 3):1–5. doi: 10.1159/000075297
   Google Scholar
• Whiteley W, Chong WL, Sengupta A, et al. Blood markers for the prognosis of ischemic stroke: a systematic review. Stroke. 2009;40(5):e380–e9. doi: 10.1161/STROKEAHA.108.528752
   PubMed Web of Science ®Google Scholar
• Howard VJ, Lutsep HL, Mackey A, et al. Influence of sex on outcomes of stenting versus endarterectomy: a subgroup analysis of the Carotid Revascularization endarterectomy versus stenting trial (CREST). Lancet Neurol. 2011;10(6):530–537. doi: 10.1016/S1474-4422(11)70080-1
   PubMed Web of Science ®Google Scholar
• Howard VJ, Voeks JH, Lutsep HL, et al. Does sex matter? thirty-day stroke and death rates after carotid artery stenting in women versus men: results from the carotid revascularization endarterectomy versus stenting trial (CREST) lead-in phase. Stroke. 2009;40(4):1140–1147. doi: 10.1161/STROKEAHA.108.541847
   PubMed Web of Science ®Google Scholar
• Derdeyn CP, Chimowitz MI, Lynn MJ, et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial. Lancet. 2014;383(9914):333–341. doi: 10.1016/S0140-6736(13)62038-3
   PubMed Web of Science ®Google Scholar
• Waje-Andreassen U, Kråkenes J, Ulvestad E, et al. IL-6: an early marker for outcome in acute ischemic stroke. Acta Neurol Scand. 2005;111(6):360–365. doi: 10.1111/j.1600-0404.2005.00416.x
   PubMed Web of Science ®Google Scholar
• Syrjänen J, Teppo A, Valtonen V, et al. Acute phase response in cerebral infarction. J Clin Pathol. 1989;42(1):63–68. doi: 10.1136/jcp.42.1.63
   PubMed Web of Science ®Google Scholar
• Idicula TT, Brogger J, Naess H, et al. Admission C – reactive protein after acute ischemic stroke is associated with stroke severity and mortality: the ’Bergen stroke study’. BMC neurol. 2009;9(1):18. doi: 10.1186/1471-2377-9-18
   PubMedGoogle Scholar
• Tsalta-Mladenov ME, Andonova SP. Peripheral blood cell count ratios as a predictor of poor functional outcome in patients with acute ischemic stroke. Neurol Res. 2023;46(3):1–7. doi: 10.1080/01616412.2023.2270336
   PubMed Web of Science ®Google Scholar
• Mullenix PS, Steele SR, Martin MJ, et al. C-reactive protein level and traditional vascular risk factors in the prediction of carotid stenosis. Arch Surg. 2007;142(11):1066–1071. doi: 10.1001/archsurg.142.11.1066
   PubMedGoogle Scholar
• Siegerink B, Rosendaal FR, Algra A. Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke. J Thromb Haemost. 2009;7(3):385–390. doi: 10.1111/j.1538-7836.2008.03266.x
   PubMed Web of Science ®Google Scholar
• Di Napoli M, Papa F, Bocola V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke. 2001;32(1):133–138. doi: 10.1161/01.STR.32.1.133
   PubMed Web of Science ®Google Scholar
• Drouet L. Fibrinogen: A treatable risk factor? Cerebrovascular Dis. 1996;6(Suppl. 1):2–6. doi: 10.1159/000108065
   Google Scholar
• Harley SL, Powell JT. Fibrinogen up-regulates the expression of monocyte chemoattractant protein 1 in human saphenous vein endothelial cells. Biochem J. 1999;341(3):739–744. doi: 10.1042/bj3410739
   PubMedGoogle Scholar
• Millán M, Sobrino T, Arenillas JF, et al. Biological signatures of brain damage associated with high serum ferritin levels in patients with acute ischemic stroke and thrombolytic treatment. Dis Markers. 2008;25(3):181–188. doi: 10.1155/2008/380356
   PubMed Web of Science ®Google Scholar
• van der DL, Grobbee DE, Roest M, et al. Serum ferritin is a risk factor for stroke in postmenopausal women. Stroke. 2005;36(8):1637–1641. doi: 10.1161/01.STR.0000173172.82880.72
   PubMed Web of Science ®Google Scholar
• Wang C, Gao L, Zhang Z-G, et al. Procalcitonin is a stronger predictor of long-term functional outcome and mortality than high-sensitivity C-reactive protein in patients with ischemic stroke. Mol Neurobiol. 2016;53(3):1509–1517. doi: 10.1007/s12035-015-9112-7
   PubMed Web of Science ®Google Scholar
• Tian D, Zhang S, He X, et al. Serum procalcitonin as a diagnostic marker in acute ischemic stroke. Neuroreport. 2015;26(1):33–37. doi: 10.1097/WNR.0000000000000298
   PubMed Web of Science ®Google Scholar
• Li Y-M, Liu X-Y. Serum levels of procalcitonin and high sensitivity C-reactive protein are associated with long-term mortality in acute ischemic stroke. J Neurolog Sci. 2015;352(1–2):68–73. doi: 10.1016/j.jns.2015.03.032
   PubMed Web of Science ®Google Scholar
• Levitt DG, Levitt MD. Human serum albumin homeostasis: a new look at the roles of synthesis, catabolism, renal and gastrointestinal excretion, and the clinical value of serum albumin measurements. Int J Gene Med. 2016;9:229. doi: 10.2147/IJGM.S102819
   PubMed Web of Science ®Google Scholar
• Kimura Y, Yamada M, Kakehi T, et al. Combination of low body mass index and low serum albumin level leads to poor functional recovery in stroke patients. J Stroke Cerebrovascular Dis. 2017;26(2):448–453. doi: 10.1016/j.jstrokecerebrovasdis.2016.10.008
   PubMed Web of Science ®Google Scholar
• González-Pacheco H, Amezcua-Guerra LM, Sandoval J, et al. Prognostic implications of serum albumin levels in patients with acute coronary syndromes. Am J Cardiol. 2017;119(7):951–958. doi: 10.1016/j.amjcard.2016.11.054
   PubMed Web of Science ®Google Scholar
• Celik IE, Yarlioglues M, Kurtul A, et al. Preprocedural albumin levels and risk of in-stent restenosis after coronary stenting with bare-metal stent. Angiology. 2016;67(5):478–483. doi: 10.1177/0003319715598084
   PubMed Web of Science ®Google Scholar
• Paar M, Rossmann C, And NC, et al. Anticoagulant action of low, physiologic, and high albumin levels in whole blood. PloS One. 2017;12(8):e182997. doi: 10.1371/journal.pone.0182997
   PubMed Web of Science ®Google Scholar
• Babu MS, Kaul S, Dadheech S, et al. Serum albumin levels in ischemic stroke and its subtypes: correlation with clinical outcome. Nutrition. 2013;29(6):872–875. doi: 10.1016/j.nut.2012.12.015
   PubMed Web of Science ®Google Scholar
• Yang X, Wang L, And ZL, et al. Serum albumin as a potential predictor of pneumonia after an acute ischemic stroke. Curr Neurovasc Res. 2020;17(4):385–393. doi: 10.2174/1567202617666200514120641
   PubMed Web of Science ®Google Scholar
• Goldwasser P, Feldman J. Association of serum albumin and mortality risk. J Clinical Epidemiol. 1997;50(6):693–703. doi: 10.1016/S0895-4356(97)00015-2
   PubMed Web of Science ®Google Scholar
• Akirov A, Masri-Iraqi H, Atamna A, et al. Low albumin levels are associated with mortality risk in hospitalized patients. Am J Med. 2017;130(12):. e1465. 11–. e. 19. doi: 10.1016/j.amjmed.2017.07.020
   Web of Science ®Google Scholar
• Zhang H, Shu Y, Zhang J, et al. Dynamics of nutritional status in dying patients with acute cerebral infarction in central China: a preliminary study. Neurol Res. 2011;33(5):503–507. doi: 10.1179/016164111X13007856084160
   PubMed Web of Science ®Google Scholar
• Gillum RF, Ingram DD, Makuc DM. Relation between serum albumin concentration and stroke incidence and death: the NHANES I epidemiologic follow-up study. Am J Epidemiol. 1994;140(10):876–888. doi: 10.1093/oxfordjournals.aje.a117176
   PubMed Web of Science ®Google Scholar
• Adiguzel A, Arsava EM, Topcuoglu MA. Temporal course of peripheral inflammation markers and indexes following acute ischemic stroke: prediction of mortality, functional outcome, and stroke-associated pneumonia. Neurol Res. 2022;44(3):224–231. doi: 10.1080/01616412.2021.1975222
   PubMed Web of Science ®Google Scholar
• Carter AM, Catto AJ, Mansfield MW, et al. Predictive variables for mortality after acute ischemic stroke. Stroke. 2007;38(6):1873–1880. doi: 10.1161/STROKEAHA.106.474569
   PubMed Web of Science ®Google Scholar
• Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American heart association/American stroke association. Stroke. 2021;52(7):e364–e467. doi: 10.1161/STR.0000000000000375
   PubMed Web of Science ®Google Scholar
• Sorond FA, Ratan RR. Ironing-out mechanisms of neuronal injury under hypoxic–ischemic conditions and potential role of iron chelators as neuroprotective agents. Antioxid Redox Signaling. 2000;2(3):421–436. doi: 10.1089/15230860050192206
   PubMed Web of Science ®Google Scholar